BNNano leverages cutting edge materials science innovation to transform, revitalize, revolutionize, and add value to industrial commodities.
Post-money valuation โ
$23.9M
As of Feb 2023 ยท from BNNano, Inc. Common Stock 2 ยท pre-money + amount raised, not a traded price
Total raised
$424,447
Across 2 rounds since 2021
Latest share price
$1.87
BNNano, Inc. Common Stock 2 offering price
Financials
FY2018โFY2024 ยท from SEC filings ยท hover any figure for its source
$51K
โ$1.2M
2018
$48K
โ$2.2M
2019
$48K
โ$2.2M
2020
$112K
โ$957K
2021
$281K
โ$717K
2022
$172K
โ$200K
2023
$686K
$158K
2024
RevenueNet income โ beside revenue when positive, below the line when a loss
Metric
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
Income statement
Revenue
$50,851
$48,283
$48,283
$112,114
$280,505
$172,312
$685,555
Cost of goods sold
$5,122
$8,381
$8,381
$34,968
$59,283
$13,596
$132,853
Gross margin
90%
83%
83%
69%
79%
92%
81%
Net income
-$1,208,527
-$2,211,223
-$2,211,223
-$956,926
-$716,910
-$200,487
$157,782
Taxes paid
$25,185
$5,593
$5,593
$5,790
$4,753
$5,359
$5,179
Balance sheet
Cash
$235,061
$196,434
$196,438
$38,169
$38,169
$38,169
$69,333
Accounts receivable
$0
$0
$0
$0
$0
$0
$0
Total assets
$355,732
$289,253
$289,257
$536,694
$169,994
$107,326
$153,986
Short-term debt
$26,628
$61,628
$44,231
$36,993
$106,932
$55,013
$5,692
Long-term debt
$1,270,000
$1,526,800
$1,526,800
$1,465,000
$1,465,000
$1,548,750
$1,503,144
Total liabilities
$1,296,628
$1,588,428
$1,571,031
$1,501,993
$1,571,932
$1,603,763
$1,508,836
Other
Headcount
โ
6
โ
6
6
6
6
Figures as reported by the issuer in the filing shown on hover. Each yearโs pill shows the assurance level of its filed statements โ audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didnโt state one. Headcount is the filingโs point-in-time count, not a year-end average. Manually corrected figures are marked โCorrectedโ.
A dashed amber step is a SAFE/note valuation cap โ a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
About this data. Figures are compiled from public sources โ SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages โ and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.